Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing
Podcast Image

The "Elevate" by MAPS Podcast

Business Education

Activity Overview

Episode publication activity over the past year

Episodes

Showing 201-225 of 225
«« ← Prev Page 3 of 3

Field Medical Stakeholders: Partnering for Today and Tomorrow - episode 1 Global Communications

02 Nov 2020

Contributed by Lukas

Kathryn Gann, Independent Consultant, serves as the moderator for this session on Global Communications. In this podcast, Robin Winter-Sperry, MD, Pre...

How COVID-19 Accelerates Orthopedic Opportunities in Ambulatory Surgery

26 Oct 2020

Contributed by Lukas

In this first of two episodes, John Pracyk, MD, PhD, MBA speaks with Patrick Vega of Vizient Advisory Solutions about ways that device companies can c...

Expert Engagement: Driving the Strategic Impact of Medical Affairs

09 Oct 2020

Contributed by Lukas

External experts play a key role in the success or failure of the innovations delivered by the pharma/biotech industry. In today’s environment, rest...

Medical Affairs Plans: from Strategic Planning to Measuring Impact - episode 1

06 Oct 2020

Contributed by Lukas

The Series Podcast Objectives are:  Understand how the medical affairs strategic planning process can drive decision making throughout the year  Gai...

Executive Leadership Perspectives on MA Strategic Planning - episode 2

11 Sep 2020

Contributed by Lukas

In this second of two podcasts, Pete Piliero, MD, VP & Head, Medical Affairs Americas, GSK Consumer Healthcare, moderates a discussion on Global/R...

Executive Leadership Perspectives on Medical Affairs Strategic Planning - Episode 1

11 Sep 2020

Contributed by Lukas

In this first of two podcasts, Pete Piliero, MD, VP & Head, Medical Affairs Americas, GSK Consumer Healthcare, moderates a discussion on Contribut...

The application of Real World Evidence in Regulatory Decision Making

28 Aug 2020

Contributed by Lukas

Cerise James, MD, moderates this podcast presentation by the MAPS Evidence Generation Focus Area Working Group in which Neil Belson, JD, discusses Rea...

European Union Medical Device Regulations (EUMDR): ep 2

22 May 2020

Contributed by Lukas

In this second podcast on the EUMDR, panelists John Pracyk, MD, PhD, MBA, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Re...

European Union Medical Device Regulations (EUMDR): ep 1 Podcast Objectives, Panel Introductions, Why EUMDR?, and What does it really mean? 

07 Apr 2020

Contributed by Lukas

Host John Pracyk, MD, PhD, MBA, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, DePuy Synthes - Spine | Johnson &a...

Transitioning between Pharma and MedTech…and vice versa: ep 6 Strategies for Transitioning

27 Feb 2020

Contributed by Lukas

What does it take to go from an external deep subject matter expert to an internal medical expert? Specializing in one area may limit your ability to ...

Transitioning between Pharma and MedTech…and vice versa: ep 5 Organization structure, team size, lift in product development

27 Feb 2020

Contributed by Lukas

Teams are traditionally smaller in MedTech than in Pharma. In MedTech companies, the MA professional may be asked to manage smaller teams and broader ...

Transitioning between Pharma and MedTech…and vice versa: ep 4 Ideal MA Leadership Qualities – communication skills, personality traits, scientific skills

27 Feb 2020

Contributed by Lukas

Do you possess the ability to empathize, but also the business acumen to understand your audience? MA professionals interact with a variety of stakeho...

Transitioning between Pharma and MedTech…and vice versa: ep 3 Customer Preferences, Patient Centricity and Payer Interactions

27 Feb 2020

Contributed by Lukas

While there are similarities in decision making between Pharma and MedTech, it can be difficult to get face time with physicians but is still relative...

Transitioning between Pharma and MedTech…and vice versa: ep 2 Transferable skills…What challenges exist?

27 Feb 2020

Contributed by Lukas

If you’re considering a career transition, asking: “What’s in it for me?” is just as important as “What’s in it for the company?” During...

Transitioning between Pharma and MedTech…and vice versa: ep 1 Podcast Objectives, Panel Introductions and Personal Stories

27 Feb 2020

Contributed by Lukas

Hosts John Pracyk, MD, PhD, MBA, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, Depuy Synthes - Spine | Johnson &...

The Dynamic World of Field Medical: Are you a driver or passenger? ep 4 America’s Got Talent and so do Field Medical Teams!

24 Feb 2020

Contributed by Lukas

Ralph Rewers, PharmD, AbbVie’s Global Head, Field Medical Excellence pulled together a group of experts who will discuss the differences in the type...

The Dynamic World of Field Medical: Are you a driver or passenger? ep 3 The MSL Role – Today and Emerging Areas

24 Feb 2020

Contributed by Lukas

Change is the only constant in the MSL role. Panelists at the session of the March 8 Field Medical Program in Miami will prepare attendees by discussi...

The Dynamic World of Field Medical: Are you a driver or passenger? ep 2 MSL: Why specialized training is a requirement and not optional.

24 Feb 2020

Contributed by Lukas

Are you keeping up with the data and science that are driving the profession? The panelists who will be highlighting the critical importance of adult ...

The Dynamic World of Field Medical: Are you a driver or passenger? ep 1 Objectives, panel introductions and what to expect at the MAPS Annual Global Meeting on March 8th

24 Feb 2020

Contributed by Lukas

Host Robin Winter-Sperry MD, Head of Global Field Based Medical Excellence & Insights at Sanofi Genzyme introduces Donna Holder PharmD, Executive ...

Stakeholder Expectations and Collaboration in the Evolving Healthcare Landscape: ep 4 From Global to Local

19 Feb 2020

Contributed by Lukas

How can global leaders set affiliates up for success? Charlotte Kremer MD MBA, EVP of Medical Affairs for Astellas, and current MAPS President, speaks...

Stakeholder Expectations and Collaboration in the Evolving Healthcare Landscape: ep 3 Commercial Engagement

19 Feb 2020

Contributed by Lukas

What does the future of MA look like from a commercial perspective? Robert "Bobby" Mulrooney, MD, General Manager, UK & Ireland for Port...

Stakeholder Expectations in the Evolving Healthcare Landscape: ep 1 Patient Centricity

19 Feb 2020

Contributed by Lukas

Patients want the best medicine and therapy available. Merinke Kuiper-Lenters, MD, a physician and patient who was diagnosed with autoimmune vasculiti...

Stakeholder Expectations and Collaboration in the Evolving Healthcare Landscape: ep 5 Partnering with Commercial R&D

11 Feb 2020

Contributed by Lukas

In theory, successfully commercializing a product is straightforward; in reality it is not. In this comprehensive discussion, Matthew McLoughlin, MD, ...

Stakeholder Expectations and Collaboration in the Evolving Healthcare Landscape: ep 2 R&D Expectations

11 Feb 2020

Contributed by Lukas

It's sometimes challenging to find insights that are actionable in development. In this podcast, Prof. Dr. med. Iris Loew-Friedrich, UCB Chief Me...

Stakeholder Expectations and Collaboration in the Evolving Healthcare Landscape: R&D Expectations

20 Jan 2020

Contributed by Lukas

It's sometimes challenging to find insights that are actionable in development. In this podcast, Iris Loew-Friendish, UCB Chief Medical Officer a...

«« ← Prev Page 3 of 3